To the Holders of Corporate Bonds

Dear Sirs,

We hereby inform you that the Extraordinary General Meeting of the Participants of LLC “AKFA MEDLINE” (Minutes No. 04-25 dated September 9, 2025) has resolved to approve the early redemption (buyback) in full of the first issue of corporate bonds (state registration No. Q-0838) at the initiative of the Company, at a price of 102.9 % of the indexed nominal value plus the amount of accrued but unpaid interest, followed by the cancellation of the redeemed bonds.

Issue Parameters (for identification purposes)

Early Redemption Terms (as of September 9, 2025)

• Buyback price per bond: UZS 12,160,909.09 (102.9 % of the indexed nominal value);
• Accrued but unpaid interest (total): UZS 5,569,121,212.12;
• Total amount payable under the issue: UZS 262,164,303,030.31 (102.9 % of the indexed nominal value + accrued interest), excluding any applicable taxes and fees.